4//SEC Filing
Climaco John M 4
Accession 0001683168-25-008564
CIK 0001729427other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:00 PM ET
Size
6.1 KB
Accession
0001683168-25-008564
Insider Transaction Report
Form 4
Climaco John M
DirectorChief Executive Officer
Transactions
- Award
Option to purchase common stock
2025-11-17+9,761→ 9,761 totalExercise: $30.00Exp: 2035-11-17→ Common Stock (9,761 underlying)
Footnotes (3)
- [F1]The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on March 11, 2025 (the "Grant Date"), subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025.
- [F2]The options set forth in the table vest as follows: 50% on the six-month anniversary of the Grant Date, 25% on the 12-month anniversary of the Grant Date, and 25% on the 18-month anniversary of the Grant Date, subject to the reporting person's continued employment on each vesting date.
- [F3]Issued in connection with the reporting person's employment with the Company.
Documents
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeother
Related Parties
1- filerCIK 0001546797
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:00 PM ET
- Size
- 6.1 KB